Go Pro
Guggenheim

Guggenheim Analyst Recommendations & Stock Picks

View the latest stock recommendations issued by analysts at Guggenheim. This page tracks publicly reported analyst upgrades and downgrades, buy/hold/sell ratings, and price target changes for publicly traded companies. All data is compiled from credible public sources and updated regularly to reflect new insights from Guggenheim's equity research team. MarketBeat is not affiliated with or endorsed by Guggenheim.

Average Return
00.00% 12-Month ROI
Total Ratings
1,137 Last 12 Months
Buy Ratings
976 Last 12 Months
Sell Ratings
6 Last 12 Months
Companies Covered
392 Last 12 Months
MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceReport DateAnalystActionPrice TargetRating12-Month Recommendation ROIDetails
CrowdStrike stock logo
CRWD
CrowdStrike
$191.95
+0.8%
8/20/2026 Reiterated RatingNeutralView details for Guggenheim rating of CrowdStrike (NASDAQ:CRWD) on 8/20/2026
Okta, Inc. stock logo
OKTA
Okta
$135.14
+0.7%
8/20/2026Boost Price Target$138.00 ➝ $162.00BuyView details for Guggenheim rating of Okta (NASDAQ:OKTA) on 8/20/2026
Target Corporation stock logo
TGT
Target
$165.35
+4.5%
8/20/2026Boost Price Target$150.00 ➝ $175.00BuyView details for Guggenheim rating of Target (NYSE:TGT) on 8/20/2026
Veeva Systems Inc. stock logo
VEEV
Veeva Systems
$248.26
-0.9%
8/20/2026Boost Price Target$232.00 ➝ $276.00BuyView details for Guggenheim rating of Veeva Systems (NYSE:VEEV) on 8/20/2026
Freenome stock logo
FRNM
Freenome
$13.81
+2.2%
8/20/2026Initiated Coverage$21.00BuyView details for Guggenheim rating of Freenome (NASDAQ:FRNM) on 8/20/2026
Autodesk, Inc. stock logo
ADSK
Autodesk
$253.82
+1.1%
8/20/2026Boost Price Target$245.00 ➝ $277.00BuyView details for Guggenheim rating of Autodesk (NASDAQ:ADSK) on 8/20/2026
SentinelOne, Inc. stock logo
S
SentinelOne
$21.20
+1.2%
8/20/2026Boost Price Target$24.00 ➝ $28.00BuyView details for Guggenheim rating of SentinelOne (NYSE:S) on 8/20/2026
Salesforce Inc. stock logo
CRM
Salesforce
$209.20
+1.8%
8/20/2026Reiterated Rating$228.00BuyView details for Guggenheim rating of Salesforce (NYSE:CRM) on 8/20/2026
Freenome stock logo
FRNM
Freenome
$13.81
+2.2%
8/20/2026Initiated Coverage$21.00BuyView details for Guggenheim rating of Freenome (NASDAQ:FRNM) on 8/20/2026
GitLab Inc. stock logo
GTLB
GitLab
$41.67
-1.0%
8/19/2026Reiterated RatingNeutralView details for Guggenheim rating of GitLab (NASDAQ:GTLB) on 8/19/2026
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
$38.66
-2.5%
8/19/2026Boost Price Target$40.00 ➝ $55.00BuyView details for Guggenheim rating of Amylyx Pharmaceuticals (NASDAQ:AMLX) on 8/19/2026
Elastic N.V. stock logo
ESTC
Elastic
$85.91
+0.0%
8/19/2026Reiterated Rating$106.00BuyView details for Guggenheim rating of Elastic (NYSE:ESTC) on 8/19/2026
The Home Depot, Inc. stock logo
HD
Home Depot
$336.04
+0.5%
8/19/2026Reiterated Rating$425.00BuyView details for Guggenheim rating of Home Depot (NYSE:HD) on 8/19/2026
Scribe Therapeutics Inc. stock logo
SCTX
Scribe Therapeutics
$34.13
+4.0%
8/18/2026Initiated Coverage$50.00BuyView details for Guggenheim rating of Scribe Therapeutics (NASDAQ:SCTX) on 8/18/2026
MongoDB, Inc. stock logo
MDB
MongoDB
$430.83
+2.5%
8/18/2026Boost Price Target$475.00 ➝ $560.00BuyView details for Guggenheim rating of MongoDB (NASDAQ:MDB) on 8/18/2026
LGN stock logo
LGN
LGN
$59.37
-1.2%
8/18/2026Reiterated Rating$115.00BuyView details for Guggenheim rating of LGN (NASDAQ:LGN) on 8/18/2026
Scribe Therapeutics Inc. stock logo
SCTX
Scribe Therapeutics
$34.13
+4.0%
8/18/2026Initiated Coverage$50.00BuyView details for Guggenheim rating of Scribe Therapeutics (NASDAQ:SCTX) on 8/18/2026
Celcuity, Inc. stock logo
CELC
Celcuity
$93.53
+3.3%
8/17/2026Boost Price Target$165.00 ➝ $175.00BuyView details for Guggenheim rating of Celcuity (NASDAQ:CELC) on 8/17/2026
Spruce Biosciences, Inc. stock logo
SPRB
Spruce Biosciences
$51.58
-0.8%
8/17/2026Reiterated Rating$123.00 ➝ $104.00BuyView details for Guggenheim rating of Spruce Biosciences (NASDAQ:SPRB) on 8/17/2026
Walmart Inc. stock logo
WMT
Walmart
$103.70
-0.1%
8/17/2026Reiterated Rating$137.00 ➝ $135.00BuyView details for Guggenheim rating of Walmart (NASDAQ:WMT) on 8/17/2026
Yesway, Inc. stock logo
YSWY
Yesway
$25.20
+2.4%
8/17/2026Boost Price Target$30.00 ➝ $32.00BuyView details for Guggenheim rating of Yesway (NASDAQ:YSWY) on 8/17/2026
ADC Therapeutics SA stock logo
ADCT
ADC Therapeutics
$1.00
+3.9%
8/17/2026Lower Price Target$5.00BuyView details for Guggenheim rating of ADC Therapeutics (NYSE:ADCT) on 8/17/2026
Liberty Media Corporation - Liberty Formula One Series C stock logo
FWONK
Liberty Media Corporation - Liberty Formula One Series C
$104.94
+0.7%
8/17/2026Boost Price Target$125.00 ➝ $134.00BuyView details for Guggenheim rating of Liberty Media Corporation - Liberty Formula One Series C (NASDAQ:FWONK) on 8/17/2026
Liberty Media Corporation - Liberty Formula One Series A stock logo
FWONA
Liberty Media Corporation - Liberty Formula One Series A
$96.52
+1.0%
8/14/2026Boost Price Target$116.00 ➝ $124.00BuyView details for Guggenheim rating of Liberty Media Corporation - Liberty Formula One Series A (NASDAQ:FWONA) on 8/14/2026
Birkenstock Holding PLC stock logo
BIRK
Birkenstock
$35.67
+3.2%
8/14/2026Reiterated Rating$60.00BuyView details for Guggenheim rating of Birkenstock (NYSE:BIRK) on 8/14/2026
Globant S.A. stock logo
GLOB
Globant
$39.66
+0.1%
8/14/2026Lower Price Target$55.00 ➝ $50.00BuyView details for Guggenheim rating of Globant (NYSE:GLOB) on 8/14/2026
The Madison Square Garden Company stock logo
MSGS
Madison Square Garden
$407.48
+2.2%
8/14/2026Boost Price Target$522.00 ➝ $584.00BuyView details for Guggenheim rating of Madison Square Garden (NYSE:MSGS) on 8/14/2026
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
$32.29
+2.1%
8/14/2026Reiterated Rating$55.00BuyView details for Guggenheim rating of Zenas BioPharma (NASDAQ:ZBIO) on 8/14/2026
Pharvaris N.V. stock logo
PHVS
Pharvaris
$36.27
-0.3%
8/13/2026Boost Price Target$39.00 ➝ $40.00BuyView details for Guggenheim rating of Pharvaris (NASDAQ:PHVS) on 8/13/2026
Unicycive Therapeutics, Inc. stock logo
UNCY
Unicycive Therapeutics
$5.63
+3.3%
8/13/2026Reiterated Rating$37.00 ➝ $25.00BuyView details for Guggenheim rating of Unicycive Therapeutics (NASDAQ:UNCY) on 8/13/2026
Erasca, Inc. stock logo
ERAS
Erasca
$17.63
+3.2%
8/13/2026Boost Price Target$20.00 ➝ $21.00BuyView details for Guggenheim rating of Erasca (NASDAQ:ERAS) on 8/13/2026
Everpure, Inc. stock logo
P
Everpure
$108.51
-1.3%
8/13/2026Boost Price Target$115.00 ➝ $150.00BuyView details for Guggenheim rating of Everpure (NYSE:P) on 8/13/2026
SCYNEXIS, Inc. stock logo
SCYX
SCYNEXIS
$5.10
-2.3%
8/13/2026Reiterated Rating$24.00 ➝ $33.00BuyView details for Guggenheim rating of SCYNEXIS (NASDAQ:SCYX) on 8/13/2026
CAVA Group, Inc. stock logo
CAVA
CAVA Group
$73.64
+2.2%
8/13/2026Lower Price Target$100.00 ➝ $95.00BuyView details for Guggenheim rating of CAVA Group (NYSE:CAVA) on 8/13/2026
STUB stock logo
STUB
STUB
$6.73
-1.5%
8/13/2026Lower Price Target$12.50 ➝ $11.00BuyView details for Guggenheim rating of STUB (NYSE:STUB) on 8/13/2026
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
$29.12
-0.2%
8/13/2026Reiterated Rating$45.00BuyView details for Guggenheim rating of ArriVent BioPharma (NASDAQ:AVBP) on 8/13/2026
Madison Square Garden Entertainment Corp. stock logo
MSGE
Madison Square Garden Entertainment
$79.99
+0.2%
8/12/2026Boost Price Target$82.00 ➝ $103.00BuyView details for Guggenheim rating of Madison Square Garden Entertainment (NYSE:MSGE) on 8/12/2026
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
$36.73
+4.0%
8/12/2026Boost Price Target$45.00 ➝ $52.00BuyView details for Guggenheim rating of Cogent Biosciences (NASDAQ:COGT) on 8/12/2026
Neurogene Inc. stock logo
NGNE
Neurogene
$38.63
+1.7%
8/12/2026Boost Price Target$69.00 ➝ $81.00BuyView details for Guggenheim rating of Neurogene (NASDAQ:NGNE) on 8/12/2026
Zura Bio Limited stock logo
ZURA
Zura Bio
$5.85
+1.7%
8/12/2026Boost Price Target$15.00 ➝ $20.00BuyView details for Guggenheim rating of Zura Bio (NASDAQ:ZURA) on 8/12/2026
Trump's New Dollar (Ad)

Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel

Watch the free briefing and see the three steps to prepare today
Tango Therapeutics, Inc. stock logo
TNGX
Tango Therapeutics
$23.88
+1.6%
8/12/2026Boost Price Target$32.00 ➝ $35.00BuyView details for Guggenheim rating of Tango Therapeutics (NASDAQ:TNGX) on 8/12/2026
Natera, Inc. stock logo
NTRA
Natera
$332.03
+2.2%
8/12/2026Boost Price Target$290.00 ➝ $360.00BuyView details for Guggenheim rating of Natera (NASDAQ:NTRA) on 8/12/2026
Life Time Group Holdings, Inc. stock logo
LTH
Life Time Group
$45.15
+1.0%
8/12/2026Reiterated Rating$50.00BuyView details for Guggenheim rating of Life Time Group (NYSE:LTH) on 8/12/2026
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
$207.77
-0.1%
8/11/2026Boost Price Target$260.00 ➝ $275.00BuyView details for Guggenheim rating of Axsome Therapeutics (NASDAQ:AXSM) on 8/11/2026
Septerna, Inc. stock logo
SEPN
Septerna
$40.00
-1.9%
8/11/2026Boost Price Target$45.00 ➝ $51.00BuyView details for Guggenheim rating of Septerna (NASDAQ:SEPN) on 8/11/2026
Tenax Therapeutics, Inc. stock logo
TENX
Tenax Therapeutics
$1.75
-1.7%
8/11/2026Set Price Target$40.00 ➝ $4.00BuyView details for Guggenheim rating of Tenax Therapeutics (NASDAQ:TENX) on 8/11/2026
Tenax Therapeutics, Inc. stock logo
TENX
Tenax Therapeutics
$1.75
-1.7%
8/11/2026Reiterated Rating$40.00 ➝ $4.00BuyView details for Guggenheim rating of Tenax Therapeutics (NASDAQ:TENX) on 8/11/2026
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
$107.96
+3.0%
8/11/2026Reiterated Rating$200.00BuyView details for Guggenheim rating of Oruka Therapeutics (NASDAQ:ORKA) on 8/11/2026
CytomX Therapeutics, Inc. stock logo
CTMX
CytomX Therapeutics
$3.28
-0.3%
8/10/2026Lower Price Target$15.00 ➝ $14.00BuyView details for Guggenheim rating of CytomX Therapeutics (NASDAQ:CTMX) on 8/10/2026
EPAM Systems, Inc. stock logo
EPAM
EPAM Systems
$110.49
+3.5%
8/10/2026Lower Price Target$165.00 ➝ $140.00BuyView details for Guggenheim rating of EPAM Systems (NYSE:EPAM) on 8/10/2026
Amgen Inc. stock logo
AMGN
Amgen
$439.33
+1.3%
8/10/2026Boost Price Target$343.00 ➝ $388.00NeutralView details for Guggenheim rating of Amgen (NASDAQ:AMGN) on 8/10/2026
ANI Pharmaceuticals, Inc. stock logo
ANIP
ANI Pharmaceuticals
$75.35
-2.5%
8/10/2026Lower Price Target$124.00 ➝ $119.00BuyView details for Guggenheim rating of ANI Pharmaceuticals (NASDAQ:ANIP) on 8/10/2026
DraftKings Inc. stock logo
DKNG
DraftKings
$26.17
+4.6%
8/10/2026Lower Price Target$35.00 ➝ $33.00BuyView details for Guggenheim rating of DraftKings (NASDAQ:DKNG) on 8/10/2026
Serve Robotics Inc. stock logo
SERV
Serve Robotics
$4.98
+5.1%
8/10/2026Lower Price Target$13.00 ➝ $7.00BuyView details for Guggenheim rating of Serve Robotics (NASDAQ:SERV) on 8/10/2026
Sionna Therapeutics, Inc. stock logo
SION
Sionna Therapeutics
$5.29
-4.2%
8/10/2026DowngradeBuyNeutralView details for Guggenheim rating of Sionna Therapeutics (NASDAQ:SION) on 8/10/2026
SpaceX stock logo
SPCX
SpaceX
$136.97
+2.2%
8/7/2026 Initiated CoverageBuyView details for Guggenheim rating of SpaceX (NASDAQ:SPCX) on 8/7/2026
Avalo Therapeutics, Inc. stock logo
AVTX
Avalo Therapeutics
$19.83
+0.1%
8/7/2026Set Price Target$50.00 ➝ $48.00BuyView details for Guggenheim rating of Avalo Therapeutics (NASDAQ:AVTX) on 8/7/2026
Sionna Therapeutics, Inc. stock logo
SION
Sionna Therapeutics
$5.29
-4.2%
8/7/2026Boost Price Target$50.00 ➝ $60.00BuyView details for Guggenheim rating of Sionna Therapeutics (NASDAQ:SION) on 8/7/2026
GH Research PLC stock logo
GHRS
GH Research
$28.33
-1.2%
8/7/2026Boost Price Target$34.00 ➝ $40.00BuyView details for Guggenheim rating of GH Research (NASDAQ:GHRS) on 8/7/2026
Monte Rosa Therapeutics, Inc. stock logo
GLUE
Monte Rosa Therapeutics
$14.30
-3.2%
8/7/2026Lower Price Target$35.00 ➝ $28.00BuyView details for Guggenheim rating of Monte Rosa Therapeutics (NASDAQ:GLUE) on 8/7/2026
Insmed, Inc. stock logo
INSM
Insmed
$125.77
+0.6%
8/7/2026Lower Price Target$207.00 ➝ $205.00BuyView details for Guggenheim rating of Insmed (NASDAQ:INSM) on 8/7/2026
Pfizer Inc. stock logo
PFE
Pfizer
$28.00
+0.8%
8/7/2026Lower Price Target$35.00 ➝ $31.00BuyView details for Guggenheim rating of Pfizer (NYSE:PFE) on 8/7/2026
Etsy Inc stock logo
ETSY
Etsy
$80.69
-0.6%
8/7/2026Boost Price Target$85.00 ➝ $95.00BuyView details for Guggenheim rating of Etsy (NYSE:ETSY) on 8/7/2026
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
$17.39
+0.6%
8/7/2026Lower Price Target$58.00 ➝ $55.00BuyView details for Guggenheim rating of Janux Therapeutics (NASDAQ:JANX) on 8/7/2026
JFrog Ltd. stock logo
FROG
JFrog
$92.13
+2.7%
8/7/2026Boost Price Target$105.00 ➝ $115.00BuyView details for Guggenheim rating of JFrog (NASDAQ:FROG) on 8/7/2026
CryoPort, Inc. stock logo
CYRX
CryoPort
$17.13
+2.5%
8/7/2026Boost Price Target$12.00 ➝ $16.00BuyView details for Guggenheim rating of CryoPort (NASDAQ:CYRX) on 8/7/2026
Verastem, Inc. stock logo
VSTM
Verastem
$6.89
+1.0%
8/7/2026Set Price Target$14.00 ➝ $12.00BuyView details for Guggenheim rating of Verastem (NASDAQ:VSTM) on 8/7/2026
Atlassian Corporation PLC stock logo
TEAM
Atlassian
$171.81
-1.8%
8/7/2026Boost Price Target$115.00 ➝ $165.00BuyView details for Guggenheim rating of Atlassian (NASDAQ:TEAM) on 8/7/2026
Cloudflare, Inc. stock logo
NET
Cloudflare
$293.16
+5.1%
8/7/2026Boost Price Target$140.00 ➝ $160.00SellView details for Guggenheim rating of Cloudflare (NYSE:NET) on 8/7/2026
Roku, Inc. stock logo
ROKU
Roku
$157.49
+0.2%
8/7/2026Downgrade$145.00 ➝ $160.00BuyNeutralView details for Guggenheim rating of Roku (NASDAQ:ROKU) on 8/7/2026
Xponential Fitness, Inc. stock logo
XPOF
Xponential Fitness
$5.17
+2.2%
8/7/2026DowngradeBuyNeutralView details for Guggenheim rating of Xponential Fitness (NYSE:XPOF) on 8/7/2026
US Foods Holding Corp. stock logo
USFD
US Foods
$109.52
+1.0%
8/7/2026Boost Price Target$115.00 ➝ $120.00BuyView details for Guggenheim rating of US Foods (NYSE:USFD) on 8/7/2026
The Trade Desk stock logo
TTD
Trade Desk
$13.18
-1.1%
8/7/2026Downgrade$25.00 ➝ $12.00BuyNeutralView details for Guggenheim rating of Trade Desk (NASDAQ:TTD) on 8/7/2026
The Trade Desk stock logo
TTD
Trade Desk
$13.18
-1.1%
8/7/2026Set Price Target$25.00 ➝ $12.00BuyNeutralView details for Guggenheim rating of Trade Desk (NASDAQ:TTD) on 8/7/2026
Relay Therapeutics, Inc. stock logo
RLAY
Relay Therapeutics
$19.44
-1.3%
8/7/2026Reiterated RatingBuyView details for Guggenheim rating of Relay Therapeutics (NASDAQ:RLAY) on 8/7/2026
Akamai Technologies, Inc. stock logo
AKAM
Akamai Technologies
$110.42
+0.3%
8/7/2026Boost Price Target$181.00 ➝ $190.00BuyView details for Guggenheim rating of Akamai Technologies (NASDAQ:AKAM) on 8/7/2026
Maplebear Inc. stock logo
CART
Maplebear
$49.83
-2.4%
8/7/2026Boost Price Target$44.00 ➝ $46.00NeutralView details for Guggenheim rating of Maplebear (NASDAQ:CART) on 8/7/2026
First Watch Restaurant Group, Inc. stock logo
FWRG
First Watch Restaurant Group
$13.03
+3.2%
8/7/2026Lower Price Target$21.00 ➝ $20.00BuyView details for Guggenheim rating of First Watch Restaurant Group (NASDAQ:FWRG) on 8/7/2026
Genmab A/S Sponsored ADR stock logo
GMAB
Genmab A/S
$33.45
+0.1%
8/7/2026Boost Price Target$40.00 ➝ $42.00BuyView details for Guggenheim rating of Genmab A/S (NASDAQ:GMAB) on 8/7/2026
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
$36.30
-1.5%
8/7/2026Boost Price Target$36.00 ➝ $42.00BuyView details for Guggenheim rating of Roivant Sciences (NASDAQ:ROIV) on 8/7/2026
Zevra Therapeutics, Inc. stock logo
ZVRA
Zevra Therapeutics
$11.87
-0.2%
8/7/2026Lower Price Target$24.00 ➝ $23.00BuyView details for Guggenheim rating of Zevra Therapeutics (NASDAQ:ZVRA) on 8/7/2026
Genius Sports Limited stock logo
GENI
Genius Sports
$8.04
+1.4%
8/6/2026Boost Price Target$11.00 ➝ $12.00BuyView details for Guggenheim rating of Genius Sports (NYSE:GENI) on 8/6/2026
Everus Construction Group, Inc. stock logo
ECG
Everus Construction Group
$125.91
+0.5%
8/6/2026Boost Price Target$160.00 ➝ $184.00BuyView details for Guggenheim rating of Everus Construction Group (NYSE:ECG) on 8/6/2026
Urogen Pharma stock logo
URGN
Urogen Pharma
$46.86
+0.1%
8/6/2026Boost Price Target$42.00 ➝ $58.00BuyView details for Guggenheim rating of Urogen Pharma (NASDAQ:URGN) on 8/6/2026
SharkNinja, Inc. stock logo
SN
SharkNinja
$181.26
+0.7%
8/6/2026Boost Price Target$175.00 ➝ $210.00BuyView details for Guggenheim rating of SharkNinja (NYSE:SN) on 8/6/2026
Adicet Bio, Inc. stock logo
ACET
Adicet Bio
$9.19
-2.0%
8/6/2026Reiterated Rating$100.00 ➝ $90.00BuyView details for Guggenheim rating of Adicet Bio (NASDAQ:ACET) on 8/6/2026
Ardent Health, Inc. stock logo
ARDT
Ardent Health
$10.98
+4.8%
8/6/2026Boost Price Target$13.00 ➝ $14.00BuyView details for Guggenheim rating of Ardent Health (NYSE:ARDT) on 8/6/2026
Arcutis Biotherapeutics, Inc. stock logo
ARQT
Arcutis Biotherapeutics
$25.08
-1.1%
8/6/2026Boost Price Target$35.00 ➝ $38.00BuyView details for Guggenheim rating of Arcutis Biotherapeutics (NASDAQ:ARQT) on 8/6/2026
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
$59.82
+1.5%
8/6/2026Lower Price Target$80.00 ➝ $78.00BuyView details for Guggenheim rating of Enliven Therapeutics (NASDAQ:ELVN) on 8/6/2026
Paycom Software, Inc. stock logo
PAYC
Paycom Software
$229.37
+1.2%
8/6/2026Boost Price Target$180.00 ➝ $225.00BuyView details for Guggenheim rating of Paycom Software (NYSE:PAYC) on 8/6/2026
Your book attached (Ad)

Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel

Download the Safe Trade Options Formula book for free before access closes
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$270.69
+1.2%
8/6/2026Boost Price Target$270.00 ➝ $287.00BuyView details for Guggenheim rating of Johnson & Johnson (NYSE:JNJ) on 8/6/2026
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
$209.46
-1.1%
8/6/2026Boost Price Target$235.00 ➝ $240.00BuyView details for Guggenheim rating of Revolution Medicines (NASDAQ:RVMD) on 8/6/2026
The Walt Disney Company stock logo
DIS
Walt Disney
$107.93
+0.6%
8/6/2026Reiterated Rating$120.00BuyView details for Guggenheim rating of Walt Disney (NYSE:DIS) on 8/6/2026
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
$374.47
+1.4%
8/6/2026Boost Price Target$420.00 ➝ $430.00BuyView details for Guggenheim rating of BeOne Medicines (NASDAQ:ONC) on 8/6/2026
Primoris Services Corporation stock logo
PRIM
Primoris Services
$77.17
-2.6%
8/6/2026Lower Price Target$162.00 ➝ $127.00BuyView details for Guggenheim rating of Primoris Services (NYSE:PRIM) on 8/6/2026
Uber Technologies, Inc. stock logo
UBER
Uber Technologies
$78.89
+0.4%
8/6/2026Reiterated Rating$125.00BuyView details for Guggenheim rating of Uber Technologies (NYSE:UBER) on 8/6/2026
McDonald's Corporation stock logo
MCD
McDonald's
$270.84
+0.6%
8/5/2026Lower Price Target$320.00 ➝ $290.00NeutralView details for Guggenheim rating of McDonald’s (NYSE:MCD) on 8/5/2026
Wayfair Inc. stock logo
W
Wayfair
$101.38
-1.9%
8/5/2026Boost Price Target$100.00 ➝ $135.00BuyView details for Guggenheim rating of Wayfair (NYSE:W) on 8/5/2026
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
$65.71
+1.9%
8/5/2026Boost Price Target$65.00 ➝ $75.00BuyView details for Guggenheim rating of Travere Therapeutics (NASDAQ:TVTX) on 8/5/2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$152.43
+2.3%
8/5/2026Boost Price Target$145.00 ➝ $146.00BuyView details for Guggenheim rating of Merck & Co., Inc. (NYSE:MRK) on 8/5/2026

MarketBeat's community ratings are surveys of what our community members think about Guggenheim and other research firms in the last 90 days. Vote "Outperform" if you believe Guggenheim's recommendations will outperform the broader market over the long term. Vote "Underperform" if you believe Guggenheim's recommendations will underperform the broader market over the long term. You may vote once every thirty days.

Log in to vote on this brokerage.
COMMUNITY RATINGS
0.0out of 5 (last 90 days)
0 of 5 stars
OUTPERFORM VOTES
0 Believe will outperform the market
UNDERPERFORM VOTES
0 Believe will underperform the market

Guggenheim's equity research team has issued ratings on 388 companies across 11 sectors over the past 12 months, covered by 34 analysts. The Guggenheim analysts below are listed by number of ratings issued in the last year.

Guggenheim Stock Coverage by Sector

Guggenheim concentrates its research most heavily in Healthcare (48.5%), Consumer Discretionary (17.9%) and Technology (13.0%). The chart below shows how Guggenheim's 392 rated companies are distributed across all 11 sectors it covers.

Guggenheim - Frequently Asked Questions

Guggenheim's analysts currently have buy-equivalent ratings on 329 companies. Recent upgrades to buy include Quanta Services, Autodesk, AppFolio, Freshworks and Guidewire Software.

Guggenheim's highest-rated analysts by MarketBeat's accuracy score include Seamus Fernandez, Joseph Osha and Vamil Divan. Rankings are based on historical rating accuracy and price target precision over the past 12 months. MarketBeat tracks 36 analysts at Guggenheim.

Guggenheim has the deepest coverage in Healthcare (48.5% of rated companies), Consumer Discretionary (17.9% of rated companies), Technology (13.0% of rated companies), Communication Services (8.7% of rated companies) and Industrials (5.9% of rated companies).

Guggenheim issued 1,137 ratings over the last 12 months across 392 companies — an average of roughly 95 rating actions per month. These include boost price target, downgrade, initiated coverage, lower price target, reiterated rating, set price target and upgrade. MarketBeat tracks every rating change as it's published so you can see the most current Guggenheim analyst actions.

A buy rating indicates the analyst expects the stock to outperform the market over the next 12 months. A hold suggests the stock will perform in line with the market. A sell rating indicates expected underperformance. Guggenheim uses Buy, Neutral, and Sell as their equivalents.